Is ICL a Good Stock to Buy? The Bull and Bear Case (2026)
Last updated November 2026
Short answer
Both cases are real, which is why the question is contested. The bull case for ICL Group Ltd (ICL) rests on Potash pricing against a low cost Dead Sea position: ICL realised ~$376 per tonne CIF on potash in the second quarter of 2026, about ~13% above the same quarter of 2025 and ~4% above the first quarter, and Potash segment EBITDA rose to ~$154 million from ~$115 million. The bear case rests on the Dead Sea Works concession covering ~652 square kilometres runs only to March 31, 2030, and ICL must win the successor concession from the Israeli state on terms the state sets, which is the largest open question in the equity. Analysts covering it publish targets from $5.45 to $6.00 against a $4.41 share price on November 16, 2026, so even the professionals disagree by 10% of their own average. We do not give a verdict. Each case is set out below at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.
ICL key stats
At $4.41 on November 16, 2026, ICL Group Ltd (ICL) has a market cap of $5.7B, a P/E of 18.4 on trailing earnings (10.2 on forward earnings) and a dividend yield of 4.76%.
- Market cap
- $5.7B
- P/E (trailing)
- 18.4
- P/E (forward)
- 10.2
- EPS (trailing 12 months)
- $0.24
- Price to book
- 0.9
- Dividend yield
- 4.76%
- Beta
- 1.00
Market cap, P/E and yield are measured at the $4.41 price on November 16, 2026, from Yahoo Finance figures pulled in November 2026. Earnings date from Yahoo Finance. Walnut is informational, not investment advice.
What's new with ICL Group Ltd (ICL)?
The last two weeks for ICL Group Ltd, as of November 17, 2026: the price move, the next earnings date, what the company filed with the SEC, and what analysts changed.
- ICL closed at $4.41 on November 16, 2026, down 5.8% over the past five trading days (from $4.68).
- On November 10, 2026, ICL Group Ltd filed a current report (6-K) with the SEC. Read the 6-K on sec.gov
Prices are daily closes from Yahoo Finance. Filings are read from SEC EDGAR every six hours. Analyst actions come from Yahoo Finance as of November 2026. Walnut is informational, not investment advice.
ICL Group Ltd. runs four businesses out of a mineral base most competitors cannot replicate. Industrial Products extracts bromine from the highly concentrated Dead Sea brine and turns it into flame retardants, clear brine fluids and specialty minerals, making ICL the largest elemental bromine producer in the world alongside Albemarle and Lanxess. Potash comes from solar evaporation ponds at Sodom in Israel and from underground mines in Catalonia, Spain. Phosphate Solutions works phosphate rock from the Negev and China into fertilisers and higher value food and industrial specialties, and Growing Solutions sells controlled release and water soluble fertilisers, biostimulants and micronutrients into agriculture, turf and ornamental markets. The company employs about ~12,000 people, reports in US dollars under IFRS as a foreign private issuer, and had ~1.29 billion ordinary shares outstanding at the end of 2025. The investment picture is a cyclical recovery running into a political deadline. Second quarter 2026 sales of ~$2.14 billion were up ~17% year over year, adjusted EBITDA reached ~$448 million against ~$351 million, and every one of the four segments grew sales. Trailing twelve month revenue is about ~$7.7 billion with adjusted EBITDA near ~$1.64 billion, and management reiterated full year adjusted EBITDA guidance of ~$1.5 billion to ~$1.7 billion. Adjusted EPS of $0.12 in the quarter edged past the roughly $0.11 consensus. The market has not rewarded it: as of October 16, 2026 the shares closed at $4.97, down about 14% year to date and 20% over twelve months, near the bottom of a $4.76 to $6.97 52-week range. Against a market capitalisation of roughly $6.4 billion and net financial liabilities of ~$2.6 billion, that is an enterprise value near 5.5 times adjusted EBITDA, cheap for a business with BBB- ratings from both S&P and Fitch. What the discount buys is exposure to the Israeli state, which owns the Dead Sea concession ICL operates under until March 31, 2030 and sets the terms of whatever replaces it. Third-quarter results are scheduled for November 11, 2026, with consensus adjusted EPS of about $0.10, slightly below a year earlier.
The bull case: what would have to be true for $6.00
The most optimistic published target on ICL is $6.00, +36.1% from the $4.41 share price on November 16, 2026. Getting there needs the following to work close to its best case, not merely to avoid going wrong.
1. Potash pricing against a low cost Dead Sea position
ICL realised ~$376 per tonne CIF on potash in the second quarter of 2026, about ~13% above the same quarter of 2025 and ~4% above the first quarter, and Potash segment EBITDA rose to ~$154 million from ~$115 million. The company reiterated full year potash sales volumes of ~4.5 million to ~4.7 million tonnes and signed a ~375,000 tonne supply agreement with IPL in India at ~$383 per tonne. Solar evaporation at Sodom sits near the low end of the global cost curve, which is why potash pricing moves ICL's earnings faster than volume does.
2. Bromine and an improving specialty mix
Industrial Products, which is effectively the bromine franchise, generated sales of ~$414 million in the quarter against ~$319 million a year earlier, and segment operating income more than doubled to ~$115 million. ICL produced about ~155 thousand tonnes of elemental bromine in 2025 against roughly ~280 thousand tonnes of capacity and consumed about ~76% of it internally in compounds. Idle capacity behind an already leading market position is the cheapest growth on the books, because a demand recovery converts to volume without new capital.
3. The Elevate cost program and the 2027 restructuring
Management formalised an enterprise wide cost program called Elevate during the quarter, targeting more than ~$350 million of annualised savings by the end of 2028 with meaningful benefit arriving in early 2027. From the start of 2027 the four current segments become Nutrition Solutions, Industrial Products, Growing Solutions and Essential Minerals, pulling the food, health and wellness businesses into a single line. The stated purpose is investor visibility, and a side effect is that specialty earnings become far easier to separate from upstream mineral earnings.
4. Pushing phosphate and plant nutrition downstream
Phosphate Solutions sold ~$722 million in the quarter, split roughly ~$399 million specialties and ~$323 million commodities, though the commodity half still threw off the larger EBITDA at about ~$83 million versus ~$53 million. Growing Solutions grew sales to ~$605 million but saw operating income slip to ~$32 million on higher sulphur and raw material costs. ICL acquired ~49.9% of Bartek Ingredients in January 2026 for roughly ~$90 million and opened a water soluble fertiliser plant in Maharashtra, India, both consistent with moving mix away from raw commodity tonnes.
The bear case: what would have to be true for $5.45
The most pessimistic published target is $5.45, +23.6% from the current price. It is neither a floor nor a forecast; it is roughly what one analyst thinks ICL Group Ltd is worth if the risks below bite instead of the drivers above.
The Dead Sea Works concession covering ~652 square kilometres runs only to March 31, 2030, and ICL must win the successor concession from the Israeli state on terms the state sets, which is the largest open question in the equity. Israeli country risk is concrete rather than theoretical here: the security situation has produced recurring charges, shekel appreciation lifts a cost base that sells in dollars, and regional shipping disruption affects both input costs and exports. Earnings remain levered to potash and phosphate pricing, so a soft grain year would give back a good part of the 2026 recovery; analysts already expect adjusted EPS to dip year over year in the third and fourth quarters (about $0.10 and $0.08), and the share price has fallen about 7% in the past month alone. Net financial liabilities rose ~$375 million in the first half to about ~$2,635 million following an ~$800 million ten year note issue at ~6.036%, comfortable at roughly ~1.6 times adjusted EBITDA but less forgiving if prices turn. Several Israeli environmental and planning matters remain open, including petitions over the Pond 4 reuse plan and an appeal against the dismissal of a Haifa Bay air pollution class action, and none of these are securities fraud claims.
The bear case deserves the same attention as the bull case, and usually gets less. If you are holding ICL already, these risks exist either way; what to check is whether any of them has moved from possible to actually happening in the reported numbers.
Where analysts land on ICL
4 analysts cover ICL, with an average target of $5.74 (+30.2% against $4.41) and a split of 0 buy, 4 hold, 0 sell. Bear in mind sell-side ratings skew positive across the whole market, so that split is not a balanced vote. The full target table, the recent rating actions by firm, and how the consensus has shifted are on the ICL forecast and price target page.
How is ICL valued?
Market cap, P/E and dividend yield at today's price are in the ICL key stats above. The business figures below come from ICL Group Ltd's reported results as of October 2026 and change when it next reports.
- Revenue (TTM): ~$7.7B, with Q2 2026 sales of ~$2.14B up ~17% year over year
- Adjusted EBITDA (TTM): ~$1.64B; FY2026 guidance reiterated at ~$1.5B to ~$1.7B
- EV / adjusted EBITDA: ~5.5x (market cap ~$6.4B plus ~$2.6B net financial liabilities)
- Net financial liabilities: ~$2.6B, about ~1.6x adjusted EBITDA; BBB- stable at both S&P and Fitch
- Dividend: ~$0.21 per share over the trailing year, a ~4.1% yield at $4.97
As of October 2026: ICL reports in US dollars under IFRS even though it is an Israeli issuer filing a Form 20-F, so no currency translation is needed to read these numbers. The reported price to earnings ratio of about 21x overstates the expense, because 2025 absorbed roughly ~$293 million of impairments, closure charges and a Dead Sea water fee provision; on adjusted trailing earnings near ~$0.41 per share the multiple at the October 16, 2026 price is closer to 12x, and on 2027 consensus of about $0.43 it is near 11.5x. Dividend policy is a payout of up to ~50% of adjusted annual net income, ~$232 million was declared against 2025 results, and the share-price decline has lifted the trailing yield to about 4.1%.
How do you decide if ICL is a buy?
Whether ICL is a buy is easier to judge through four narrower questions:
- Thesis: do you believe the bull case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold ICL indirectly through an index or sector ETF before adding more.
What would change your mind on ICL
Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.
- Bull case breaks if: Potash pricing against a low cost Dead Sea position stalls in the reported numbers. A shift in the narrative around them is not enough on its own.
- Bear case breaks if: the Dead Sea Works concession covering ~652 square kilometres runs only to March 31, 2030, and ICL must win the successor concession from the Israeli state on terms the state sets, which is the largest open question in the equity fails to materialise over several reporting periods while the drivers keep compounding.
- Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.
For the full picture, see the ICL stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about ICL against your real portfolio and see your actual exposure before deciding.
Your questions about ICL Group Ltd
Ask Walnut's AI anything about ICL and see how it fits what you own.
FAQ
Is ICL a good stock to buy right now?
+
That depends on which case you find more convincing, and both are on this page. The bull case rests on Potash pricing against a low cost Dead Sea position, with revenue (ttm) at ~$7.7B, with Q2 2026 sales of ~$2.14B up ~17% year over year. The bear case rests on the Dead Sea Works concession covering ~652 square kilometres runs only to March 31, 2030, and ICL must win the successor concession from the Israeli state on terms the state sets, which is the largest open question in the equity. Analysts covering it are spread from $5.45 to $6.00, a spread wide enough to show the question is contested. If you believe the thesis, the questions that matter next are sizing and overlap; timing comes after. Walnut is not an investment adviser and this is not a recommendation.
Should I sell ICL?
+
Nobody can answer that for you, and a more useful version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. The Dead Sea Works concession covering ~652 square kilometres runs only to March 31, 2030, and ICL must win the successor concession from the Israeli state on terms the state sets, which is the largest open question in the equity. If that risk is what you were worried about and it is now playing out, take it seriously. If the price simply fell while the thesis held, the situation is different. The most pessimistic published target is $5.45, +23.6% from the $4.41 price, which is one analyst's downside case. It is not a floor. Walnut is not an investment adviser.
What is the bull case for ICL?
+
Potash pricing against a low cost Dead Sea position. ICL realised ~$376 per tonne CIF on potash in the second quarter of 2026, about ~13% above the same quarter of 2025 and ~4% above the first quarter, and Potash segment EBITDA rose to ~$154 million from ~$115 million. The most optimistic analyst target on ICL is $6.00, +36.1% from the $4.41 price. That figure is only reachable if this thesis works close to its best case.
What is the bear case for ICL?
+
The Dead Sea Works concession covering ~652 square kilometres runs only to March 31, 2030, and ICL must win the successor concession from the Israeli state on terms the state sets, which is the largest open question in the equity. Israeli country risk is concrete rather than theoretical here: the security situation has produced recurring charges, shekel appreciation lifts a cost base that sells in dollars, and regional shipping disruption affects both input costs and exports. Earnings remain levered to potash and phosphate pricing, so a soft grain year would give back a good part of the 2026 recovery; analysts already expect adjusted EPS to dip year over year in the third and fourth quarters (about $0.10 and $0.08), and the share price has fallen about 7% in the past month alone. Net financial liabilities rose ~$375 million in the first half to about ~$2,635 million following an ~$800 million ten year note issue at ~6.036%, comfortable at roughly ~1.6 times adjusted EBITDA but less forgiving if prices turn. Several Israeli environmental and planning matters remain open, including petitions over the Pond 4 reuse plan and an appeal against the dismissal of a Haifa Bay air pollution class action, and none of these are securities fraud claims. The most pessimistic published target is $5.45, +23.6% from the current price, which is roughly what one analyst thinks the stock is worth if these risks bite and the drivers do not.
What does ICL Group Ltd do?
+
ICL Group is an Israeli specialty minerals company that mines potash and bromine from the Dead Sea and sells phosphate and plant nutrition products worldwide.
What would have to change for ICL to stop being worth holding?
+
Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Potash pricing against a low cost Dead Sea position) stalling in the reported numbers (a change in the narrative alone does not count), the risk above (the Dead Sea Works concession covering ~652 square kilometres runs only to March 31, 2030, and ICL must win the successor concession from the Israeli state on terms the state sets, which is the largest open question in the equity) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.
What does ICL Group actually do?
+
It is a specialty minerals and chemicals company built on two mineral endowments: the highly concentrated brine of the Dead Sea, which yields potash, bromine and magnesium, and phosphate rock from the Negev desert and China. Those raw materials feed four segments covering flame retardants, potash fertiliser, phosphate specialties for food and industry, and specialty plant nutrition.
Does ICL pay a dividend?
+
Yes, quarterly. The board declared ~$0.06 per share on August 4, 2026, payable September 16, 2026, after ~$0.05 in each of the two prior quarters. Dividends over the trailing year total about $0.21 per share, a yield near 4.1% at the October 16, 2026 close of $4.97. Policy is a payout of up to ~50% of adjusted annual net income, which means the dividend moves with the fertiliser cycle rather than following a fixed growth path.
Walnut is informational, not investment advice, and gives no verdict on ICL. Analyst targets referenced here come from a November 2026 pull of published third-party research and change constantly. The share price is the last one Yahoo Finance reported on November 16, 2026. Verify current figures with your broker before acting on them.